We are live on ! Find out more
Canada Life

Canada Life Portfolio holdings

AUM $55.8B
1-Year Est. Return 26.04%
This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+26.04%
3 Year Est. Return
+87.85%
5 Year Est. Return
+117.08%
10 Year Est. Return
+382.61%
AUM
$41.7B
AUM Growth
-$513M
Cap. Flow
+$3.71B
Cap. Flow %
8.9%
Top 10 Hldgs %
22.48%
Holding
2,272
New
15
Increased
1,336
Reduced
732
Closed
38

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$953M
2
NTES icon
NetEase
NTES
+$668M
3
RYAAY icon
Ryanair
RYAAY
+$454M
4
PDD icon
Pinduoduo
PDD
+$309M
5
CRH icon
CRH
CRH
+$189M

Sector Composition

Rank Sector Weight
1 Technology 27.13%
2 Healthcare 13.38%
3 Financials 12.23%
4 Consumer Discretionary 11.62%
5 Communication Services 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOOS
1951
Canada Goose Holdings
GOOS
$904M
$107K ﹤0.01%
7,288
+3,556
+95% +$58K
WINA icon
1952
Winmark
WINA
$1.19B
$107K ﹤0.01%
287
+178
+163% +$64.6K
EFXT
1953
Enerflex
EFXT
$2.69B
$106K ﹤0.01%
18,374
+8,338
+83% +$56K
OLP
1954
One Liberty Properties
OLP
$532M
$106K ﹤0.01%
5,613
-1
-0% -$20
TGTX icon
1955
TG Therapeutics
TGTX
$8.19B
$104K ﹤0.01%
12,471
+6,900
+124% +$96.2K
MAG
1956
DELISTED
MAG Silver
MAG
$103K ﹤0.01%
9,950
+5,420
+120% +$60.3K
RCKT icon
1957
Rocket Pharmaceuticals
RCKT
$351M
$102K ﹤0.01%
4,987
+3,368
+208% +$61.2K
NWLI
1958
DELISTED
National Western Life Group, Inc. Class A
NWLI
$102K ﹤0.01%
234
+157
+204% +$69K
MCRB icon
1959
Seres Therapeutics
MCRB
$46.3M
$101K ﹤0.01%
2,130
ZNTL icon
1960
Zentalis Pharmaceuticals
ZNTL
$350M
$101K ﹤0.01%
5,018
+3,839
+326% +$97.4K
EBF icon
1961
Ennis
EBF
$548M
$100K ﹤0.01%
4,715
+3,113
+194% +$66.1K
RYZ
1962
Ryerson Holding Corp
RYZ
$1.39B
$100K ﹤0.01%
3,428
+2,563
+296% +$86.9K
UVSP icon
1963
Univest Financial
UVSP
$1.22B
$100K ﹤0.01%
5,790
+3,283
+131% +$60.4K
CLDX icon
1964
Celldex Therapeutics
CLDX
$3.02B
$99K ﹤0.01%
3,615
+1,914
+113% +$60K
SAGE
1965
DELISTED
Sage Therapeutics
SAGE
$99K ﹤0.01%
4,789
+2,800
+141% +$80.9K
VVX icon
1966
V2X
VVX
$2.72B
$99K ﹤0.01%
+1,912
New +$96.1K
CMCO icon
1967
Columbus McKinnon
CMCO
$596M
$98K ﹤0.01%
2,818
+1,545
+121% +$58.9K
VKTX icon
1968
Viking Therapeutics
VKTX
$3.86B
$97K ﹤0.01%
8,759
+4,233
+94% +$60.5K
DCBO
1969
Docebo
DCBO
$528M
$96K ﹤0.01%
2,382
+1,692
+245% +$67K
CTBI icon
1970
Community Trust Bancorp
CTBI
$1.42B
$95K ﹤0.01%
2,771
+1,659
+149% +$60.6K
FMNB icon
1971
Farmers National Banc Corp
FMNB
$941M
$95K ﹤0.01%
8,231
+4,726
+135% +$60.3K
PLRX icon
1972
Pliant Therapeutics
PLRX
$65.6M
$95K ﹤0.01%
5,486
+3,615
+193% +$62.7K
RMAX icon
1973
RE/MAX Holdings
RMAX
$198M
$95K ﹤0.01%
7,309
-15,279
-68% -$265K
SFIX
1974
Stitch Fix
SFIX
$547M
$95K ﹤0.01%
27,580
ACEL icon
1975
Accel Entertainment
ACEL
$973M
$92K ﹤0.01%
+8,393
New +$93.6K

Similar funds

Canada Life's Q3 2023 Portfolio in Review

As of Q3 2023, Canada Life held 2,272 positions worth $41.7B, down 1.2% from $42.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Canada Life deployed $3.71B of net new capital in Q3 2023, opening 15 new positions and adding to 1,336 existing holdings. Its largest new stake was Kenvue: 1,734,143 shares worth $34.8M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Kinder Morgan, an estimated $76.6M trimmed.

  • Canada Life's largest Q3 2023 buy was Kenvue: 1,734,143 shares worth $34.8M.
  • Canada Life added most to TSMC in Q3 2023, an estimated $953M increase.
  • Canada Life's biggest Q3 2023 reduction was Kinder Morgan, cutting an estimated $76.6M.
  • Canada Life fully exited Life Storage, Inc. in Q3 2023, selling an estimated $18.8M.
  • Canada Life's ten largest holdings make up 22% of its $41.7B portfolio in Q3 2023.
  • Canada Life opened 15 new positions and closed 38 in Q3 2023.
  • Canada Life's portfolio value fell 1.2% quarter-over-quarter to $41.7B.

Based on Canada Life's 13F filing for Q3 2023, filed 14 Nov 2023.